Viewing Study NCT03204734


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-03-09 @ 1:59 PM
Study NCT ID: NCT03204734
Status: UNKNOWN
Last Update Posted: 2017-07-02
First Post: 2017-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module